Scholars@Duke
Journal cover image

SERUM AUTOANTIBODY LOWERING BY THE ANTI-FCRN MONOCLONAL ANTIBODY, NIPOCALIMAB, CORRELATES WITH CLINICAL IMPROVEMENT IN GENERALIZED MYASTHENIA GRAVIS PATIENTS

Publication ,  Conference
Guptill, J; Antozzi, C; Bril, V; Gamez, J; Meuth, SG; Nowak, R; Quan, D; Sevilla, T; Ling, L; Zhu, Y; Karcher, K; Ramchandren, S; Sun, H
Published in: MUSCLE & NERVE
2022

Duke Scholars

Jeffrey Guptill
Author Jeffrey Guptill Neurology, Neuromuscular Disease

Published In

MUSCLE & NERVE

EISSN

1097-4598

ISSN

0148-639X

Publication Date

2022

Volume

65

Start / End Page

S4 / S4

Related Subject Headings

  • Neurology & Neurosurgery
  • 32 Biomedical and clinical sciences
  • 31 Biological sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Guptill, J., Antozzi, C., Bril, V., Gamez, J., Meuth, S. G., Nowak, R., … Sun, H. (2022). SERUM AUTOANTIBODY LOWERING BY THE ANTI-FCRN MONOCLONAL ANTIBODY, NIPOCALIMAB, CORRELATES WITH CLINICAL IMPROVEMENT IN GENERALIZED MYASTHENIA GRAVIS PATIENTS. In MUSCLE & NERVE (Vol. 65, pp. S4–S4).
Guptill, Jeffrey, Carlo Antozzi, Vera Bril, Josep Gamez, Sven G. Meuth, Richard Nowak, Dianna Quan, et al. “SERUM AUTOANTIBODY LOWERING BY THE ANTI-FCRN MONOCLONAL ANTIBODY, NIPOCALIMAB, CORRELATES WITH CLINICAL IMPROVEMENT IN GENERALIZED MYASTHENIA GRAVIS PATIENTS.” In MUSCLE & NERVE, 65:S4–S4, 2022.
Guptill J, Antozzi C, Bril V, Gamez J, Meuth SG, Nowak R, Quan D, Sevilla T, Ling L, Zhu Y, Karcher K, Ramchandren S, Sun H. SERUM AUTOANTIBODY LOWERING BY THE ANTI-FCRN MONOCLONAL ANTIBODY, NIPOCALIMAB, CORRELATES WITH CLINICAL IMPROVEMENT IN GENERALIZED MYASTHENIA GRAVIS PATIENTS. MUSCLE & NERVE. 2022. p. S4–S4.
Journal cover image

Published In

MUSCLE & NERVE

EISSN

1097-4598

ISSN

0148-639X

Publication Date

2022

Volume

65

Start / End Page

S4 / S4

Related Subject Headings

  • Neurology & Neurosurgery
  • 32 Biomedical and clinical sciences
  • 31 Biological sciences
  • 11 Medical and Health Sciences